Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients-Reference-Cited by-同舟云学术

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

Published:2018-05-04 Issue:6 Volume:8 Page:e00968
ISSN:2162-3279
Container-title:Brain and Behavior
language:en
Short-container-title:Brain Behav

Author:

Nociti Viviana¹²^ORCID,Biolato Marco³,De Fino Chiara¹,Bianco Assunta¹,Losavio Francesco Antonio¹^ORCID,Lucchini Matteo¹,Marrone Giuseppe³,Grieco Antonio³,Mirabella Massimiliano¹

Affiliation:

1. Multiple Sclerosis Center; Neuroscience Area, Neuroscience, Aging, Head and Neck and Orthopaedics Sciences Department; Fondazione Policlinico Universitario Gemelli; Catholic University of Sacred Heart; Rome Italy

2. Fondazione Don Gnocchi-ONLUS; Milan Italy

3. Liver Transplant Medicine Unit; Gastroenterological Area, Gastroenterological and Endocrino-Metabolical Sciences Department; Fondazione Policlinico Universitario Gemelli; Catholic University of Sacred Heart; Rome Italy

Publisher

Wiley

Subject

Behavioral Neuroscience

Reference49 articles.

1. Effect of high-dose intravenous methyl-prednisolone treatment on intraocular pressure in multiple sclerosis patients with relapse;Acar;European Neurology,2012

2. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis;Alvarez;Journal of Hepatology,1999

3. Treatment of acute relapses in multiple sclerosis;Berkovich;Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics,2013

4. Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity;Carrier;Clinics and Research in Hepatology and Gastroenterology,2013

5. Methylprednisolone-induced hepatotoxicity: Experiences from global adverse drug reaction surveillance;Caster;European Journal of Clinical Pharmacology,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report;Frontiers in Neurology;2024-02-29

2. Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis;BMJ Neurology Open;2023-09

3. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives;Clinical and Experimental Medicine;2023-07-08

4. Long‐term outcomes of drug‐induced autoimmune‐like hepatitis after pulse steroid therapy;Hepatology Research;2023-07-05

5. Exploring the mechanism of Yishen Daluo decoction in the treatment of multiple sclerosis based on network pharmacology and in vitro experiments;Journal of Traditional Chinese Medical Sciences;2023-04